Skip to content
BidBenchmark

Indefinite delivery vehicle

WE PHARMA, INC.

IDIQ FOR PHARMACEUTICAL PRODUCTS FOR CDER RESEARCH STUDIES. INCLUDES BRAND NAME AND/OR GENERIC PHARMACEUTICALS TO INCLUDE SMALL MOLECULE AND PEPTIDE THERAPEUTICS, DRUG-DEVICE COMBINATION PRODUCTS, AND CONTRAST AGENTS. EO 14398
PIID
75F40126D00023
Award key
CONT_IDV_75F40126D00023_7524
Recipient UEI
EWAMVJSFNK29
Source as of
—
Current award value
—3
Obligated to date
$99,9192
Potential with options
$4,000,0003
Awarding agency
Department of Health and Human ServicesFood and Drug Administration
Contractor
WE PHARMA, INC.
Place of performance
—
Set-aside
No set-aside used
Pricing
Firm Fixed Price
Competition
Competed under SAP2 offers received
Period of performance
Sep 15, 2026 — Sep 14, 2031
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 11, 2026Initial award$99,919.36—

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.gov—Sep 13, 2026usaspending_contract_csv@2026.08.2820d83944398
contractor_idUSAspending.gov—Sep 13, 2026usaspending_contract_csv@2026.08.2820d83944398
current_award_valueUSAspending.gov—Sep 13, 2026usaspending_contract_csv@2026.08.2820d83944398
naics_codeUSAspending.gov—Sep 13, 2026usaspending_contract_csv@2026.08.2820d83944398
potential_award_valueUSAspending.gov—Sep 13, 2026usaspending_contract_csv@2026.08.2820d83944398
psc_codeUSAspending.gov—Sep 13, 2026usaspending_contract_csv@2026.08.2820d83944398
total_obligatedUSAspending.gov—Sep 13, 2026usaspending_contract_csv@2026.08.2820d83944398

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 1 transaction records parsed from USAspending.gov, retrieved Sep 13, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.